Cargando…
Genomic Epidemiology of SARS-CoV-2 in Western Burkina Faso, West Africa
Background: After its initial detection in Wuhan, China, in December 2019, SARS-CoV-2 has spread rapidly, causing successive epidemic waves worldwide. This study aims to provide a genomic epidemiology of SARS-CoV-2 in Burkina Faso. Methods: Three hundred and seventy-seven SARS-CoV-2 genomes obtained...
Autores principales: | Sawadogo, Yacouba, Galal, Lokman, Belarbi, Essia, Zongo, Arsène, Schubert, Grit, Leendertz, Fabian, Kanteh, Abdoulie, Sesay, Abdul Karim, Erhart, Annette, Bañuls, Anne-Laure, Tarnagda, Zékiba, Godreuil, Sylvain, Tinto, Halidou, Ouedraogo, Abdoul-Salam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782145/ https://www.ncbi.nlm.nih.gov/pubmed/36560792 http://dx.doi.org/10.3390/v14122788 |
Ejemplares similares
-
Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country
por: Kaboré, Odilon D., et al.
Publicado: (2023) -
Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022) -
Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2016) -
Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
por: Rouamba, Toussaint, et al.
Publicado: (2021) -
Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2015)